to incorporate human factors into product design and submissions.

The FDA Guidance on Human Factors specifically emphasizes the role of HFE in reducing user errors that might lead to unsafe use scenarios. It directs manufacturers to include usability engineering in design control processes, aiming to generate evidence of device effectiveness and safety.

Documentation

A robust documentation process is critical for demonstrating compliance and supporting submissions. This includes:

• Human Factors File (HFF) – A comprehensive collection of documents capturing the human factors research, analyses, and usability tests conducted throughout the product lifecycle. This should include:
• Usability assessments
• User interface design specifications
• Risk analysis results related to user interactions
• Justifications for design decisions based on user feedback
• Validation results demonstrating the effectiveness of the design
• Usability Engineering Reports – Detailed reports that outline the methodology, findings, and conclusions from usability studies. Use these reports to illustrate how user feedback has been incorporated into design iterations.
• Risk Management Files – Document the risk analysis and management processes related to user interactions, following ISO 14971 principles.
• Design History File (DHF) – This should include all design-related documentation and evaluations necessary to demonstrate compliance with design control requirements.

Review/Approval Flow

The review and approval process for combination products with a focus on human factors engineering involve multiple stages, including the following:

1. Pre-Submission – Manufacturers are encouraged to engage in pre-submission meetings with the FDA to discuss human factors strategies and obtain preliminary feedback on their proposed approaches.
2. Submission of Human Factors Documentation – When submitting a 510(k), PMA, or BLA, it is vital to include HFE documentation as part of the application. Address potential user errors and document how interface designs mitigate these risks.
3. Agency Review – The FDA and other regulatory bodies will review submitted HFE documentation to evaluate whether it adequately addresses safety and effectiveness. Common points of scrutiny include…
• Clarity of user interface design
• Testing representative of actual user conditions
• Mitigation strategies for identified risks
4. Post-Market Surveillance – Following approval, manufacturers must implement strategies to monitor user interactions in the real-world setting. This is crucial for gathering ongoing data to refine products and ensure sustained compliance.

Common Deficiencies

Common deficiencies observed during regulatory submissions related to human factors engineering often stem from inadequate documentation or insufficient user testing. Key areas to focus on include:

• Poor Risk Analysis – Failure to identify potential user-related risks adequately. Regulators expect a thorough justification and analysis of how the design factors into user safety.
• Lack of Usability Testing – Submissions that do not provide empirical evidence from usability testing are often rejected or delayed. It’s essential to engage intended users early in the design process.
• Inclusion of Anecdotal Evidence – Reliance solely on anecdotal experiences to support usability claims without substantial data from testing can lead to critical questions from regulators regarding product validation.
• Insufficient User Studies – The absence of data from various user demographics (e.g., patients, health care professionals) can create gaps in understanding potential misuse scenarios.

Regulatory Affairs Specific Decision Points

In the realm of regulatory affairs, several decision points arise when integrating human factors engineering during combination product submissions:

1. Determining Submission Type – It is essential to discern whether changes to a combination product mandate a new application or can be categorized as variations. The extent of design change, particularly regarding usability, will heavily influence this decision.
2. Justifying Bridging Data – When leveraging existing studies or data from a similar product or previous submission, manufacturers must articulate how this bridging data is relevant to user safety and product functionality.
3. User Evaluation Timeline – Establishing a timeline for usability testing is critical. Incorporating user feedback should not just occur at the end of the design process but should be an iterative component that informs ongoing design decisions.

Conclusion

Successful integration of human factors engineering into the design controls of combination products is not just a regulatory requirement; it is an essential aspect of delivering safe and effective products to market. By understanding the regulatory framework, documenting HFE processes meticulously, and engaging users throughout the design lifecycle, regulatory affairs professionals can navigate the complexities of submission processes effectively while aligning with agency expectations.